ADVANCED PANCREATIC CANCER
Clinical trials for ADVANCED PANCREATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED PANCREATIC CANCER trials appear
Sign up with your email to follow new studies for ADVANCED PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune cells armed with antibodies take on pancreatic cancer
Disease control OngoingThis early-phase study tests a new treatment called EGFR-BATs for people with advanced pancreatic cancer that has not responded to standard chemotherapy. The treatment uses the patient's own immune cells, which are trained in a lab to better attack cancer cells. The main goal is …
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 17, 2026 13:58 UTC
-
New hope for pancreatic cancer: experimental combo enters human testing
Disease control OngoingThis early-stage study tests a new drug called AB680 combined with three other medications (zimberelimab, nab-paclitaxel, and gemcitabine) in people with advanced pancreatic cancer that has not been treated before. The main goals are to check safety and find the right dose. About…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated May 17, 2026 13:55 UTC
-
Old drugs, new hope? phase 1 trial combines common meds for advanced cancer
Disease control OngoingThis early-phase trial tests a combination of three common drugs—metformin, digoxin, and simvastatin—in people with advanced pancreatic cancer or other solid tumors that have not responded to standard treatments. The main goal is to find the safest dose and check for side effects…
Matched conditions: ADVANCED PANCREATIC CANCER
Phase: PHASE1 • Sponsor: Danae Hamouda, MD • Aim: Disease control
Last updated May 17, 2026 13:54 UTC